Submitted by Anonymous (not verified) on 11 March 2025 - 12:16
Orphan designation: Venetoclax Treatment of mantle cell lymphoma, 12/12/2017 Withdrawn
Source:
Orphan designation: Venetoclax Treatment of mantle cell lymphoma, 12/12/2017 Withdrawn